Ignite Creation Date:
2025-12-24 @ 6:59 PM
Ignite Modification Date:
2026-03-30 @ 6:00 AM
Study NCT ID:
NCT06453057
Status:
RECRUITING
Last Update Posted:
2025-02-17
First Post:
2024-06-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Autologous Tumor-Infiltrating Lymphocyte (GT307) for Treatment of Patients with Solid Tumours
Sponsor:
Grit Biotechnology
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
GRIT-CD-CHN-307-005
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None